PPA
MACK

Parametric Portfolio Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Parametric Portfolio Associates’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,386
Closed -$58K – 4071
2017
Q1 		$58K Sell
2,386
-1,378
-37% -$34.5K ﹤0.01% 3730
2016
Q4 		$121K Buy
3,764
+299
+9% +$12.8K ﹤0.01% 3682
2016
Q3 		$173K Buy
3,465
+353
+11% +$14.7K ﹤0.01% 3608
2016
Q2 		$132K Buy
3,112
+217
+7% +$11.8K ﹤0.01% 3694
2016
Q1 		$191K Buy
2,895
+998
+53% +$52.1K ﹤0.01% 3758
2015
Q4 		$118K Sell
1,897
-3,215
-63% -$226K ﹤0.01% 3837
2015
Q3 		$342K Buy
5,112
+99
+2% +$8.08K ﹤0.01% 2908
2015
Q2 		$488K Buy
5,013
+577
+13% +$54.9K ﹤0.01% 3299
2015
Q1 		$415K Sell
4,436
-240
-5% -$20.4K ﹤0.01% 3376
2014
Q4 		$416K Buy
4,676
+2,107
+82% +$153K ﹤0.01% 3370
2014
Q3 		$177K Buy
+2,569
New +$137K ﹤0.01% 3646
2014
Q2 		– Sell
-1,837
Closed -$73K – 3844
2014
Q1 		$73K Sell
1,837
-239
-12% -$10.2K ﹤0.01% 3763
2013
Q4 		$87K Buy
2,076
+622
+43% +$18K ﹤0.01% 3741
2013
Q3 		$43K Buy
+1,454
New +$50.9K ﹤0.01% 3783

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Parametric Portfolio Associates's MACK Position: Q2 2017 in Review

Parametric Portfolio Associates sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2017, closing a stake of 2,386 shares — an estimated $58K sold.

Parametric Portfolio Associates first reported a position in MACK in Q3 2013 and held it in 14 quarters. The position peaked at $488K in Q2 2015. 119 funds tracked by Wall St. Rank hold MACK as of Q2 2017.

  • Parametric Portfolio Associates reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 2,386 Merrimack Pharmaceuticals, Inc. shares in Q2 2017, an estimated $58K.
  • Parametric Portfolio Associates first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2013 and held it in 14 quarters.
  • Parametric Portfolio Associates's Merrimack Pharmaceuticals, Inc. position peaked at $488K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2017.

Based on Parametric Portfolio Associates's 13F filing for Q2 2017, filed 11 Aug 2017.